Wegovy tablets and standard Wegovy injections appear to produce broadly similar weight loss results, based on separate clinical trials
Retatrutide is an investigational, triple agonist (GLP, GIP [gastric inhibitory polypeptide], and GCGR [glucagon]) being evaluated for obesity and type-2 diabetes mellitus
Reliable platforms usually offer customer support, transparent policies, and safety assurances
Across 13 partner dispensers, several carry active or recent FDA warning letters, one is in active Chapter 11, and another sat at the center of the February 2026 Hims/Hers GLP-1 fallout
The study is strengthened by the use of iohexol-measured GFR, frequent UACR assessments, and a low drop-out rate